Routine laboratory tests, liver and kidney function, and tumor markers including cancer-associated antigen 19-9, carcinoembryonic antigen, alpha-fetoprotein, beta-human chorionic gonadotropin, and squamous cell carcinoma antigen showed no significant abnormalities, with slightly elevated squamous cell carcinoma. This evidence concerns the gene CEACAM5 and neoplasm.